Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.65 GBX
-2.67%
Market Closed
Updated:
Apr 28, 2024
Fusion Antibodies PLC
Selling, General & Administrative
|
Fusion Antibodies PLC
Selling, General & Administrative Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Selling, General & Administrative
-£2.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Selling, General & Administrative
-£155.2m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Selling, General & Administrative
-£18.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Selling, General & Administrative
-£16.3m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Selling, General & Administrative
-£39.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Selling, General & Administrative
-£45.6m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-29%
|
See Also
What is Fusion Antibodies PLC's Selling, General & Administrative?
Selling, General & Administrative
-2.3m
GBP
-2.3m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Selling, General & Administrative amounts to -2.3m GBP.
What is Fusion Antibodies PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
0%
0%
Over the last year, the Selling, General & Administrative growth was 25%. The average annual Selling, General & Administrative growth rates for Fusion Antibodies PLC have been 5% over the past three years .
You don't have any saved screeners yet
